Alberto Ospina Stella

Author

UNSW Sydney ORCID

Also Known As

A Stella, A.O. Stella, Alberto O Stella, Alberto O. Stella, Alberto Ospina, Alberto Ospina Stella, Alberto Stella

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

UNSW Sydney The University of Sydney New South Wales Department of Health Garvan Institute of Medical Research St Vincent's Hospital Sydney

About

Alberto Ospina Stella is an author at UNSW Sydney specializing in medicine, immunology, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	334
2	Cell Biology	2	2	47
3	Natural Sciences	1	1	14
4	Allergy	1	1	71
5	Cellular Physiology	1	1	14

Alberto Ospina Stella

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19 Hesham Abdelhady, Marwa Abdelrazik, Zakee Abdi, JAMA	2021	208
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis, EBioMedicine	2022	155
SARS-CoV-2 neutralizing antibodies: Longevity, breadth, and evasion by emerging viral variants Fiona Tea, Alberto Ospina Stella, Anupriya Aggarwal, PLoS Medicine	2021	154
A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection Claudio Counoupas, Matt D. Johansen, Alberto Ospina Stella, npj Vaccines	2021	83
Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection Arunasingam Abayasingam, Harikrishnan Balachandran, David Agapiou, Cell Reports Medicine Viral PersistenceSars-cov-2 InfectionMedicineAdaptive Immune SystemHumoral Response	2021	80
SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern Anupriya Aggarwal, Alberto Ospina Stella, Gregory J. Walker, Monoclonal Antibody TherapiesViral DiagnosticsImmunodeficienciesHumoral ResponseViral Pathogenesis	2021	71
Immunisation of ferrets and mice with recombinant SARS-CoV-2 spike protein formulated with Advax-SM adjuvant protects against COVID-19 infection Lei Li, Yoshikazu Honda‐Okubo, Ying Huang, Vaccine VaccinationCovid-19 InfectionVaccine DevelopmentVaccine TargetViral Pathogenesis	2021	68
Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability Deborah L. Burnett, Katherine Jackson, David B. Langley, Immunity	2021	54
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia Anupriya Aggarwal, Alberto Ospina Stella, Gregory J. Walker, Nature Microbiology	2022	54
Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses Harikrishnan Balachandran, Chansavath Phetsouphanh, David Agapiou, Cell Reports	2022	46

Page 1